Zobrazeno 1 - 10
of 24
pro vyhledávání: '"P C Caron"'
Autor:
Jennifer K. Lue, Efrat Luttwak, Alfredo Rivas-Delgado, Helen Irawan, Alexander Boardman, Philip C. Caron, Kevin David, Zachary Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Alison Moskowitz, Ariela Noy, M. Lia Palomba, Ralphael Steiner, Robert Stuver, Pallawi Torka, Santosha Vardhana, Andrew D. Zelenetz, Heiko Schoder, Brandon Imber, Joachim Yahalom, Yanming Zhang, Pallavi Galera, Ahmet Dogan, Umut Aypar, Gilles Salles
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/1eae0d2949b448a4bc8746adc272a82a
Autor:
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, Michelle Okwali, Irem Isgor, Philip C. Caron, Zachary Epstein-Peterson, Paola Ghione, Paul Hamlin, Jennifer Lue, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Alison Moskowitz, Ariela Noy, Colette Owens, Lia M. Palomba, Pallawi Torka, Pallavi Galera, Andrew D. Zelenetz, Gilles Salles, Lorenzo Falchi
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The combination of rituximab and lenalidomide (R-len) stands as an established treatment for relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL). However, the reproducibility of clinical trial results in routine clinical practice is unknow
Externí odkaz:
https://doaj.org/article/165097c826464008a67270b7f0865d5a
Autor:
William T. Johnson, Zachary D. Epstein-Peterson, Nivetha Ganesan, Timothy Pak, Tiffany Chang, Phuong Dao, Alison J. Moskowitz, Robert N. Stuver, Paola Ghione, Natasha Galasso, Niloufer Khan, M. Lia Palomba, Philip C. Caron, Anita Kumar, Roni Tamari, Jennifer K. Lue, Ariela Noy, Lorenzo Falchi, Andrew M. Intlekofer, Boglarka Gyurkocza, Miguel-Angel Perales, Michael Scordo, A. Zara Herskovits, Gilles Salles, Santosha A. Vardhana, Steven M. Horwitz
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/0f6302de165c41d99c8fe9ce37b7a728
Autor:
Fushen Sha, Michelle Okwali, Anna Alperovich, Philip C. Caron, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Erel Joffe, Niloufer Khan, Anita Kumar, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette Owens, Lia M. Palomba, Ildefonso Rodriguez-Rivera, David Straus, Gottfried von Keudell, Andrew D. Zelenetz, Joachim Yahalom, Ahmet Dogan, Heiko Schöder, Venkatraman E. Seshan, Gilles Salles, Anas Younes, Connie L. Batlevi
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 2, Pp 1-9 (2022)
Abstract Between 1998 and 2009, a total of 295 patients (median age 58, 53% females) with newly diagnosed early-stage follicular lymphoma (FL) were managed at Memorial Sloan Kettering Cancer Center. Approximately half of patients (137, 46%) underwent
Externí odkaz:
https://doaj.org/article/50c12e5101aa448db50c1d686239c9d6
Autor:
Sabela Bobillo, Erel Joffe, David Sermer, Patrizia Mondello, Paola Ghione, Philip C. Caron, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Anita Kumar, Matthew J. Matasar, Connie L. Batlevi, Alison Moskowitz, Ariela Noy, Collette N. Owens, M. Lia Palomba, David Straus, Gottfried von Keudell, Ahmet Dogan, Andrew D. Zelenetz, Venkatraman E. Seshan, Anas Younes
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-6 (2021)
Abstract Although methotrexate (MTX) is the most widely used therapy for central nervous system (CNS) prophylaxis in patients with diffuse large B-cell lymphoma (DLBCL), the optimal regimen remains unclear. We examined the efficacy of different proph
Externí odkaz:
https://doaj.org/article/da2cd3491fa94fc7a249c5f39c64ee22
Autor:
Richard J. Lin, Colette N. Owens, Esther Drill, Augustine Iannotta, Mayan Oliveros, Dylan L. Schick, Ariela Noy, John F. Gerecitano, Pamela R. Drullinsky, Philip C. Caron, Anita Kumar, Matthew J. Matasar, Craig Moskowitz, Beatriz Korc-Grodzicki, Andrew D. Zelenetz, Gilles A. Salles, Paul A. Hamlin
Publikováno v:
Haematologica, Vol 107, Iss 5 (2021)
Diffuse large B-cell lymphoma (DLBCL) predominantly affects older adults with suboptimal therapeutic outcomes due to increased treatment-related mortality and toxicities in vulnerable patients, clinically defined by geriatric impairments such as func
Externí odkaz:
https://doaj.org/article/addc2a88dd6f4f718d5313e1a1df2a7a
Publikováno v:
The Journal of Immunology. 148:1149-1154
L and H chain cDNAs of M195, a murine mAb that binds to the CD33 Ag on normal and leukemic myeloid cells, were cloned. The cDNAs were used in the construction of mouse/human IgG1 and IgG3 chimeric antibodies. In addition, humanized antibodies were co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dc3ab3377fd734fecc02a27a01c34b0
https://doi.org/10.4049/jimmunol.148.4.1149
https://doi.org/10.4049/jimmunol.148.4.1149
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(10)
HuM195 is a recombinant humanized IgG1 monoclonal antibody reactive with CD33, a Mr 67,000 glycoprotein expressed on early myeloid progenitor cells and myeloid leukemia cells. HuM195 has been shown to rapidly target and saturate acute myeloid leukemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d179efe40167f62a853c941b02233ef9
https://pubmed.ncbi.nlm.nih.gov/10537338
https://pubmed.ncbi.nlm.nih.gov/10537338
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(6)
Humanized anti-CD33 monoclonal antibody HuM195 specifically targets myeloid leukemias in vivo and has been shown to produce molecular remissions in patients with acute promyelocytic leukemia who are in clinical remission. Previous human trials have u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::525412ab5a06d966cb230ed9372d4f9f
https://pubmed.ncbi.nlm.nih.gov/9626458
https://pubmed.ncbi.nlm.nih.gov/9626458
Autor:
P C, Caron, D A, Scheinberg
Publikováno v:
Cancer investigation. 15(4)
With the increasing knowledge of the mechanisms of immune-mediated cytotoxicity, immunotherapeutic strategies are rapidly being incorporated into chemotherapy treatment schemes for acute and chronic leukemias. This includes the use of mAbs, immunotox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec4fb2bfa58f8199dfa343fdf3b4565d
https://pubmed.ncbi.nlm.nih.gov/9246157
https://pubmed.ncbi.nlm.nih.gov/9246157